Abstract:Loss of functional small bowel surface area causes short bowel syndrome (SBS), intestinal failure, and parenteral nutrition (PN) dependence. The gut adaptive response following resection may be difficult to predict, and it may take up to 2 yr to determine which patients will wean from PN. Here, we examined features of gut microbiota and bile acid (BA) metabolism in determining adaptation and ability to wean from PN. Stool and sera were collected from healthy controls and from patients with SBS (n = 52) with ileostomy, jejunostomy, ileocolonic, and jejunocolonic anastomoses fed with PN plus enteral nutrition or who were exclusively enterally fed. We undertook 16S rRNA gene sequencing, BA profiling, and 7α-hydroxy-4-cholesten-3-one (C4) quantitation with LC-MS/MS and serum amino acid analyses. Patients with SBS exhibited altered gut microbiota with reduced gut microbial diversity compared with healthy controls. We observed differences in the microbiomes of patients with SBS with ileostomy versus jejunostomy, jejunocolonic versus ileocolonic anastomoses, and PN dependence compared with those who weaned from PN. Stool and serum BA composition and C4 concentrations were also altered in patients with SBS, reflecting adaptive changes in enterohepatic BA cycling. Stools from patients who were weaned from PN were enriched in secondary BAs including deoxycholic acid and lithocholic aicd. Shifts in gut microbiota and BA metabolites may generate a favorable luminal environment in select patients with SBS, promoting the ability to wean from PN. Proadaptive microbial species and select BA may provide novel targets for patient-specific therapies for SBS.NEW & NOTEWORTHY Loss of intestinal surface area causes short bowel syndrome, intestinal failure, and parenteral nutrition dependence. We analyzed the gut microbiota and bile acid metabolome of a large cohort of short bowel syndrome adult patients with different postsurgical anatomies. We report a novel analysis of the microbiome of patients with ileostomy and jejunostomy. Enrichment of specific microbial and bile acid species may be associated with the ability to wean from parenteral nutrition.

[Metabolic Changes in Patients with Short Bowel Syndrome and the Nutritional Support Therapy].

Management of nutrition and contemporary treatment for short bowel syndrome

Rehabilitation Therapy for Short Bowel Syndrome

Short Bowel Syndrome: A Paradigm for Intestinal Adaptation to Nutrition?

Effect of Growth Hormone, Glutamine, and Enteral Nutrition on Intestinal Adaptation in Patients with Short Bowel Syndrome

Intestinal failure and short bowel syndrome

Morphological Adaptation In Adult Short Bowel Syndrome Undergoing Intestinal Rehabilitation

Effects of Bowel Rehabilitation and Combined Trophic Therapy on Intestinal Adaptation in Short Bowel Patients.

Nutritional therapy for an infant with jejuno-colostomy

Altered Fecal Microbiome and Metabolome Profiles in Rat Models of Short Bowel Syndrome

Transition of Decade in Short Bowel Syndrome in China: Yesterday, Today, and Tomorrow

The adaptation of the remained intestine and rehabilitative therapy in patients with short bowel syndrome

Experience on Enteral Nutrition in Short Bowel Syndrome

Long-term Nutritional Assessment in Children with Short Bowel Syndrome

Fecal microbiome and bile acid metabolome in adult short bowel syndrome

Pathophysiology and clinical manifestations of short bowel syndrome

Navigating nutrition and hydration care in the adult patient with short bowel syndrome

Bacterial Translocation:The Core of Gut Microbiota Dysbiosis in Patients with Short Bowel Syndrome

Advances in nutritional metabolic therapy to impede the progression of critical illness

[Nutritional Support in the Treatment of Patients with Gastrointestinal Cancer].

Changes of Drug Pharmacokinetics in Patients with Short Bowel Syndrome: A Systematic Review